Report Detail

Pharma & Healthcare Global Plasminogen Market Insights, Forecast to 2025

  • RnM2931881
  • |
  • 12 February, 2019
  • |
  • Global
  • |
  • 119 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Plasminogen, the proenzyme of the fibrinolytically active enzyme plasmin, is a single chain glycoprotein with a molecular weight of about 90,000-94,000 Da (2). Various isoelectric forms exist and can be separated by means of isoelectric focusing (IEF).

The complete amino acid sequence contains 790 amino acids. Native plasminogen (glu-plasminogen) has a N-terminal glutamic acid group. Partial plasma proteolysis gives rise to a molecule with N-terminal lysine (lysplasminogen).

Currently, the product has obtained the designation of orphan drug by the US Food and Drug Administration (FDA) and by the European Medicines Agency (EMA). Clinical trials are still underway to obtain Marketing Authorization in the United States and in Europe (EU). The report mainly targeting the research status, predicted competitive landscape, market potential and future trends of plasminogen market.
Plasminogen was originally used as an orphan drug for the treatment of congenital plasminogen deficiency, but the researchers found that he had positive effects on wound care and Diabetic Foot Ulcer treatment. And there is hope that the amputation costs and pain of such patients will be greatly reduced. Once FDA certification is available in the Diabetic Foot Ulcer area, it will benefit significantly from the 10 billion USD amputation market.
China's demand is the biggest and the most direct in the entire potential market. The main reason is that China's gradual growth in per capita consumption and has a relatively good medical system. In addition, China has the largest number of people with diabetes in the world. The market demand is obvious.
If it only acts as an orphan drug, it had almost no development prospects and market, with Congenital Plasminogen Deficiency as an example, the global prevalence around 10 thousand people, we expect 2000-3000 of these people may use the drugs, but the income is far less than the R & D expenditure. But the research team is optimistic about its potential use, especially in wound care and Diabetic Foot Ulcer treatment.
The global Plasminogen market is valued at 11400 million US$ in 2018 and will reach 16500 million US$ by the end of 2025, growing at a CAGR of 4.8% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Plasminogen market based on company, product type, end user and key regions.

This report studies the global market size of Plasminogen in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Plasminogen in these regions.
This research report categorizes the global Plasminogen market by top players/brands, region, type and end user. This report also studies the global Plasminogen market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Kedrion
Prometic
Genentech (Roche)
Boehringer Ingelheim
Kyowa Hakko Kirin
Omeros Corporation

Market size by Product
Intravenous Injection
Eye Drops
Market size by End User
Ligneous Conjunctivitis
Diabetic Foot
Wound Healing
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Plasminogen market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Plasminogen market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Plasminogen companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Plasminogen submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Plasminogen are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Plasminogen market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Plasminogen Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Plasminogen Market Size Growth Rate by Product
      • 1.4.2 Intravenous Injection
      • 1.4.3 Eye Drops
    • 1.5 Market by End User
      • 1.5.1 Global Plasminogen Market Size Growth Rate by End User
      • 1.5.2 Ligneous Conjunctivitis
      • 1.5.3 Diabetic Foot
      • 1.5.4 Wound Healing
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Plasminogen Market Size
      • 2.1.1 Global Plasminogen Revenue 2014-2025
      • 2.1.2 Global Plasminogen Sales 2014-2025
    • 2.2 Plasminogen Growth Rate by Regions
      • 2.2.1 Global Plasminogen Sales by Regions
      • 2.2.2 Global Plasminogen Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Plasminogen Sales by Manufacturers
      • 3.1.1 Plasminogen Sales by Manufacturers
      • 3.1.2 Plasminogen Sales Market Share by Manufacturers
      • 3.1.3 Global Plasminogen Market Concentration Ratio (CR5 and HHI)
    • 3.2 Plasminogen Revenue by Manufacturers
      • 3.2.1 Plasminogen Revenue by Manufacturers (2014-2019)
      • 3.2.2 Plasminogen Revenue Share by Manufacturers (2014-2019)
    • 3.3 Plasminogen Price by Manufacturers
    • 3.4 Plasminogen Manufacturing Base Distribution, Product Types
      • 3.4.1 Plasminogen Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Plasminogen Product Type
      • 3.4.3 Date of International Manufacturers Enter into Plasminogen Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Plasminogen Sales by Product
    • 4.2 Global Plasminogen Revenue by Product
    • 4.3 Plasminogen Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Plasminogen Breakdown Data by End User

    6 North America

    • 6.1 North America Plasminogen by Countries
      • 6.1.1 North America Plasminogen Sales by Countries
      • 6.1.2 North America Plasminogen Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Plasminogen by Product
    • 6.3 North America Plasminogen by End User

    7 Europe

    • 7.1 Europe Plasminogen by Countries
      • 7.1.1 Europe Plasminogen Sales by Countries
      • 7.1.2 Europe Plasminogen Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Plasminogen by Product
    • 7.3 Europe Plasminogen by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Plasminogen by Countries
      • 8.1.1 Asia Pacific Plasminogen Sales by Countries
      • 8.1.2 Asia Pacific Plasminogen Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Plasminogen by Product
    • 8.3 Asia Pacific Plasminogen by End User

    9 Central & South America

    • 9.1 Central & South America Plasminogen by Countries
      • 9.1.1 Central & South America Plasminogen Sales by Countries
      • 9.1.2 Central & South America Plasminogen Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Plasminogen by Product
    • 9.3 Central & South America Plasminogen by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Plasminogen by Countries
      • 10.1.1 Middle East and Africa Plasminogen Sales by Countries
      • 10.1.2 Middle East and Africa Plasminogen Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Plasminogen by Product
    • 10.3 Middle East and Africa Plasminogen by End User

    11 Company Profiles

    • 11.1 Kedrion
      • 11.1.1 Kedrion Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Kedrion Plasminogen Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Kedrion Plasminogen Products Offered
      • 11.1.5 Kedrion Recent Development
    • 11.2 Prometic
      • 11.2.1 Prometic Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Prometic Plasminogen Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Prometic Plasminogen Products Offered
      • 11.2.5 Prometic Recent Development
    • 11.3 Genentech (Roche)
      • 11.3.1 Genentech (Roche) Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Genentech (Roche) Plasminogen Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Genentech (Roche) Plasminogen Products Offered
      • 11.3.5 Genentech (Roche) Recent Development
    • 11.4 Boehringer Ingelheim
      • 11.4.1 Boehringer Ingelheim Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Boehringer Ingelheim Plasminogen Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Boehringer Ingelheim Plasminogen Products Offered
      • 11.4.5 Boehringer Ingelheim Recent Development
    • 11.5 Kyowa Hakko Kirin
      • 11.5.1 Kyowa Hakko Kirin Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Kyowa Hakko Kirin Plasminogen Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Kyowa Hakko Kirin Plasminogen Products Offered
      • 11.5.5 Kyowa Hakko Kirin Recent Development
    • 11.6 Omeros Corporation
      • 11.6.1 Omeros Corporation Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Omeros Corporation Plasminogen Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Omeros Corporation Plasminogen Products Offered
      • 11.6.5 Omeros Corporation Recent Development

    12 Future Forecast

    • 12.1 Plasminogen Market Forecast by Regions
      • 12.1.1 Global Plasminogen Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Plasminogen Revenue Forecast by Regions 2019-2025
    • 12.2 Plasminogen Market Forecast by Product
      • 12.2.1 Global Plasminogen Sales Forecast by Product 2019-2025
      • 12.2.2 Global Plasminogen Revenue Forecast by Product 2019-2025
    • 12.3 Plasminogen Market Forecast by End User
    • 12.4 North America Plasminogen Forecast
    • 12.5 Europe Plasminogen Forecast
    • 12.6 Asia Pacific Plasminogen Forecast
    • 12.7 Central & South America Plasminogen Forecast
    • 12.8 Middle East and Africa Plasminogen Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Plasminogen Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Plasminogen . Industry analysis & Market Report on Plasminogen is a syndicated market report, published as Global Plasminogen Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Plasminogen market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,065.40
      4,598.10
      6,130.80
      3,595.80
      5,393.70
      7,191.60
      613,041.00
      919,561.50
      1,226,082.00
      325,377.00
      488,065.50
      650,754.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report